Skip to main content
. 2022 Oct 21;25(Suppl 6):e26009. doi: 10.1002/jia2.26009
Abstract MO43 – Table 1. Independent risk factors of SARS‐CoV2 infection in PLHIV.
Variable Variable Adjusted prevalence rate ratio (95% confidence interval) p‐value
Age*Sex 18‐34 Men 1 0.0004
Age*Sex 18‐34 Women 1.719 (1.109; 2.664) 0.0004
Age*Sex 35‐49 Men 0.837 (0.705; 0.993) 0.0004
Age*Sex 35‐49 Women 0.953 (0.669; 1.357) 0.0004
Age*Sex 50‐64 Men 0.651 (0.520; 0.814) 0.0004
Age*Sex 50‐64 Women 0.887 (0.619; 1.270) 0.0004
Age*Sex ≥65 Men 0.648 (0.432; 0.972) 0.0004
Age*Sex ≤65 Women 0.660 (0.299; 1.454) 0.0004
Origin: Continent Europe 1 <0.0001
Origin: Continent Americas 1.659 (1.428; 1.928) <0.0001
Origin: Continent Others 1.601 (1.129; 2.269) <0.0001
Origin: Continent Missing 0.943 (0.714; 1.245) <0.0001
MSM (or Bisexual) No 1 0.0024
MSM (or Bisexual) Yes 1.378 (1.120; 1.694) 0.0024
Transexual No 1 0.6871
Transexual Yes 0.937 (0.682; 1.287) 0.6871
AIDS‐defining disease No 1 0.7953
AIDS‐defining disease Yes 1.028 (0.835; 1.265) 0.7953
Plasma HIV viral load Detectable 1 0.5664
Plasma HIV viral load <50 copies/mL 1.078 (0.834; 1.392) 0.5664
CD4 T‐cell counta CD4 T‐cell count1 0.995 (0.984; 1.007) 0.4156
CD8 T‐cell counta CD8 T‐cell counta 0.994 (0.986; 1.003) 0.2044
Active syphilis No 1 0.0001
Active syphilis Yes 1.507 (1.227; 1.850) 0.0001
on ART No 1 0.2299
on ART Yes 0.724 (0.427; 1.227) 0.2299
Type of ART (3rd drug) InSTI 1 0.2725
Type of ART (3rd drug) NNRTI 1.160 (0.961; 1.399) 0.2725
Type of ART (3rd drug) IP 1.085 (0.900; 1.308) 0.2725
NRTI backbone TAF/FTC 1 0.6372
NRTI backbone TDF/FTC 1.067 (0.785; 1.448) 0.6372
NRTI backbone ABC/3TC 1.091 (0.904; 1.317) 0.6372
NRTI backbone Other 1.169 (0.944; 1.448) 0.6372
NRTI backbone No NRTI 1.033 (0.783; 1.363) 0.6372

aAdjusted prevalence rate ratio per 50 units increase.